Drug utilization pattern of antiepileptic drugs: A pharmacoepidemiologic and pharmacovigilance study in a tertiary teaching hospital in India

Asian Journal of Pharmaceutical and Clinical Research

Volumn 4, Issue 1, 2011, Pages 96-99

  Pal, Abhisek ^a   Prusty, Shakti K ^a   Sahu, Pratap K ^a   Swain, Truptirekha ^b  

^a SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

^b S C B MEDICAL COLLEGE   (India)

Author keywords

Antiepileptic drugs; Pharmacoepidemiology; Pharmacovigilance; Teaching hospital

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; LAMOTRIGINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ABSENCE; ADOLESCENT; ADULT; AGED; ARTICLE; ATAXIA; ATONIC SEIZURE; CHILD; COMBINATION CHEMOTHERAPY; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; EPILEPSY; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MONOTHERAPY; MYOCLONUS SEIZURE; PHARMACOEPIDEMIOLOGY; PRESCHOOL CHILD; PRESCRIPTION; QUESTIONNAIRE; SCHOOL CHILD; SEX DIFFERENCE; SIMPLE PARTIAL SEIZURE; TEACHING HOSPITAL; TERTIARY HEALTH CARE; TONIC CLONIC SEIZURE; TONIC SEIZURE; UNSPECIFIED SIDE EFFECT;

EID: 79957473391     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Sander JW, Shorvon SD. Epidemiology of the epilepsies. Journal of Neurology, Neurosurgery and Psychiatry. 1996; 61: 433-443.
2. Shorvon SD. The epidemiology and treatment of chronic and refractory epilepsy. Epilepsia. 1996; 37 (suppl.2): S1-S3.
3. Hauser WA. Recent developments in the epidemiology of epilepsy. Acta Neurologica Scandinavica. 1995; 162 (suppl.): 17-21.
4. Sander JW, Hart YM, Johnson AL, Shorvon SD. () National general practice study of epilepsy: newly diagnosed epileptic seizures in a general population. Lancet. 1990; 336: 1267-1271.
5. Sridharan R. Epidemiology of epilepsy. Current Science. 2002; 82: 664-670.
6. Heinemann U, Draguhn A and Ficker E. Strategies for the development of drugs for pharmacoresistant epilepsies. Epilepsia. 1994; 35(5): 10-21
7. McCabe PH. New antiepileptic drugs for 21st Century. Exp Opin Pharmacother. 2000; 1(4): 633-674.
8. Wrechen KW, Pantaleo N. Evaluation of outpatient adverse drug reactions leading to hospitalization. Am J Health Syst Pharm. 2003; 60(3): 253-259.
9. Deckers CL. Place of Polytherapy in the early treatment of epilepsy. CNS drugs. 2002; 16: 155-163.
10. Wong IC, Lhatoo SD. Adverse reaction to new anticonvulsant drugs. Drug Saf. 2000; 23(1): 55-56.
11. Gilliam F. Optimising health outcomes in active epilepsy. Neurology. 2002; 8(5): 9-20.
12. Edwards IR, Aronson JK. Adverse drug reactions: definition, diagnosis and management. Lancet. 2000; 356: 1255-1259.
13. Steven HL, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992; 49: 2229-2232.
14. Anonymous. Proposal for revised classification of epilepsies and epileptic syndromes Communication on classification and terminology of the International League against Epilepsy. Epilepsia. 1989; 30: 389-399.
15. Loiseau P, Dche B, Loiseau J. () Classification of epilepsies and epileptic syndromes in two different samples of patients. Epilepsia. 1991; 32: 303-309.
16. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota. Epilepsia. 1993; 34: 453-468.
17. Sidenvall R, Forsgren L, Blomquist HK and Heijbel J. A community based prospective incidence study of epileptic seizures in children. Acta Paediatrica. 1993; 82: 60-65.
18. Forsgren L, Edvinsson SO, Blomquist HK, Heijbel J, Sidenvall R. Epilepsy in a population of mentally retarded children and adults. Epilepsy Research. 1990; 6: 234-248.
19. Chen LC, Chen YF, Yang LL, Chou MH, Lin MF. Drug utilization pattern of antiepileptic drugs and traditional Chinese medicine in a general hospital in Taiwan-a pharmacoepidemiologic study. Journal of Clinical Pharmacy and Therapeutics. 2000; 25: 125-129.
20. Radhakrisnan K, Nayak SD, Kumar SP, Sarma PS. () Profile of antiepileptic pharmacotherapy in tertiary referral centre in South India: Pharmacoepidemiology and pharmacoeconomic study. Epilepsia. 1999; 40: 179-185.
21. French JA. Refractory epilepsy: Clinical overview. Epilepsia. 2007; 48 (suppl 1): 3-7.
22. Pellock JM. Standard approach to antiepileptic drug treatment in the United States. Epilepsia. 1994; 35(4): 11-18.
23. Chadwick D. Standard approach to antiepileptic drug treatment in the United Kingdom. Epilepsia. 1994; 35 (4): 3-10.
24. Mattson RH. Medical management of epilepsy in adults. Neurology. 1998; 51 (suppl.4): S15-S20.
25. Reynolds EH, Shorvon SD. Monotherapy or Polytherapy for epilepsy? Epilepsia. 1981; 22: 1-10.
26. Hanssens Y, Deleu D, AlBalushi K, AlHashar A, Al-Zakwani I. Drug utilization pattern of antiepileptic drugs: a pharmacoepidemiologic study in Oman. Journal of Clinical Pharmacy and Therapeutics. 2002; 27: 357-364.
27. Roopa BS, Narayan SS, Sharma GRK, Rodrigues RJ, Kulkarni C. Pattern of adverse drug reactions to antiepileptic drugs: a cross sectional one year survey at a tertiary care hospital. Pharmacoepidemiology and Drug safety. 2008; 17: 807-812.
28. Wallance SJ. Newer antiepileptic drugs: advantages and disadvantages. Brain Dev. 2002; 23(5): 277-283.
29. Murphy BM, Frigo LC. Development, implementation and results of a successful multi-disciplinary adverse drug reactions reporting program in a University teaching Hospital. Hosp Pharm. 1993; 28: 1199-1204.
30. Gonzdez MG, Caroca CM, Paris E. Adverse drug reactions (ADRs) in hospitalised paediatric patients a prospective study. Int J Clin Pharmacol Ther. 1998; 36(10): 503-533.
31. Chayasirisobhon S. The Mechanism of Medically Refractory Temporal Lobe Epilepsy. Acta Neurol Taiwan. 2009; 18: 155-160.
32. Hendrik MPH, Aldenkamp AP, Alpherts WCJ, Vermulen J. Memory Complaint in Medically Refractory epilepsy: Relationship to Epilepsy related factors. Epilepsy & Behaviour. 2002; 3: 165-172.
33. Brellmann SR, Hopwood MJ. Major depression in temporal lobe epilepsy with hippocampal sclerosis: Clinical and imaging Correlates. J Neurol Neurosurg Psychiatry. 2007; 78: 1226-1230.
34. Enwere OO, Falade CO, Salako BL. Drug prescribing pattern at the medical outpatient clinic of a tertiary hospital in Southwestern Nigeria. Pharmacoepidemiology and Drug Safety. 2007; 16: 1244-1249.
35. State Drug Management Unit. Govt. of Orissa, Health and Family Welfare Department. Essential Drug List. 4th Revised Edition, Bhubaneswar; July 2006.